What makes rare disease work challenging for big pharma companies is that many of the assumptions about the business of pharma no longer apply. “It's a different business model, if you will ...

Even more recently, AbbVie has joined the list of big pharma admirers of ADCs to launch a $10.1 billion deal to acquire ImmunoGen. The motivation behind the move arrives not only in taking on the ...

I don't think big mergers are likely in the imminent future. How do you view the overall pharma business scenario? The branded generics business grows slower than the commodity business, but it lasts ...

Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.

IPC Indice de Precios Y Cotizaciones 51,877.12-163.89-0.31% ...

After hours: March 19 at 7:52:21 PM EDT Loading Chart for VRNA ...

19 March 2025 UK biotech Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (I-O) and antibody drug conjugate (ADC)-based therapies, today announced a ...

After hours: March 19 at 7:55:16 PM EDT Loading Chart for RPRX ...

A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo Former Republican Representative ...

BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Naomi Wolf's The Pfizer Papers questions the Covid-19 vaccine approval process, claiming rushed development led to reproductive issues and widespread health concerns Listen to Story Naomi Wolf’s The ...